Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers
NCT00432770 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2007-04-20
Summary
The purpose of this study is to establish the overall safety and tolerability of ARC1779 in healthy volunteers, and to characterize its pharmacokinetic and pharmacodynamic profile with respect to parameters of platelet function and von Willebrand Factor activity.
Conditions
Interventions
- DRUG
-
ARC1779
Sponsors & Collaborators
-
Archemix Corp.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-12-31
- Completion
- 2007-03-31
Countries
- United States
Study Locations
More Related Trials
-
Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)
NCT01963260 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients
NCT03951623 ·Status: COMPLETED ·Phase: PHASE1
-
A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347
NCT03275740 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease
NCT05318534 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).
NCT04188379 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients
NCT05217719 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)
NCT02868060 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
NCT07194850 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia
NCT07286032 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)
NCT03275454 ·Status: COMPLETED ·Phase: PHASE1
-
The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment
NCT03673215 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
NCT01976104 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months
NCT05046327 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)
NCT04021173 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia
NCT02094417 ·Status: COMPLETED ·Phase: PHASE2
-
Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months
NCT04516967 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia
NCT02227693 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia
NCT05785819 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure
NCT01972529 ·Status: COMPLETED ·Phase: PHASE3
-
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy
NCT00102323 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
NCT04278924 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)
NCT02279173 ·Status: COMPLETED ·Phase: PHASE3
-
TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia
NCT03136445 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet Volunteers, Longitudinal and Multi-omic Study
NCT07137429 ·Status: RECRUITING
-
Study to Evaluate Safety and Efficacy in Adult Subjects With ITP
NCT02273960 ·Status: COMPLETED ·Phase: PHASE1/PHASE2